Allergan reiterated its opposition to Valeant’s $53 billion hostile takeover offer, despite the recent calls from big shareholders to start negotiating.
from WSJ.com: What’s News US http://ift.tt/1tbcnos
from Bobby Caples
from WordPress http://ift.tt/1rEL9Kj
from Bobby Caples
No comments:
Post a Comment